InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| R848 (Resiquimod) | Omicron variants breakthrough infection elicited higher specific memory immun... | 2023 | Virol Sin. | Yu P. et al. | DOI: 10.1016/j.virs.2022.12.008 |
| Flagellin FliC VacciGrade™ | The Spike protein of SARS-CoV-2 signals via Tlr2 in zebrafish. | 2022 | Dev Comp Immunol. | Tyrkalska S.D. et al. | DOI: 10.1016/j.dci.2022.104626 |
| pFUSE2-CLIg-hK | Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of ne... | 2022 | NPJ Vaccines | Tran T.T. et al. | DOI: 10.1038/s41541-022-00586-7 |
| QUANTI-Blue™ | Calmodulin as a Key Regulator of Exosomal Signal Peptides. | 2022 | Cells | Ono K. et al. | DOI: 10.3390/cells12010158 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carci... | 2022 | Int J Mol Sci. | Imamura Y. et al. | DOI: 10.3390/ijms24010697 |
| 293/TLR4-MD2-CD14 | Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carci... | 2022 | Int J Mol Sci. | Imamura Y. et al. | DOI: 10.3390/ijms24010697 |
| MSU Crystals | Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. | 2022 | J Neuroinflammation | Chen C. et al. | DOI: 10.1186/s12974-022-02682-w |
| Poly(dA:dT) | Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. | 2022 | J Neuroinflammation | Chen C. et al. | DOI: 10.1186/s12974-022-02682-w |
| MDP | Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. | 2022 | J Neuroinflammation | Chen C. et al. | DOI: 10.1186/s12974-022-02682-w |
| FLA-ST (Standard or Ultrapure) | Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. | 2022 | J Neuroinflammation | Chen C. et al. | DOI: 10.1186/s12974-022-02682-w |
| Poly(I:C) (HMW) VacciGrade™ | Poly(I:C) treatment prevents skin tumor formation in the preclinical HPV8 tra... | 2022 | J Invest Dermatol. | Hufbauer M. et al. | DOI: 10.1016/j.jid.2022.12.007 |
| Hygromycin B Gold | Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriati... | 2022 | Cell Rep. | Veras F.P. et al. | DOI: 10.1016/j.celrep.2022.111897 |
| RAW-Blue™ Cells | Synthesis and evaluation of a new class of MIF-inhibitors in activated macrop... | 2022 | Eur J Med Chem. | Garai J. et al. | DOI: 10.1016/j.ejmech.2022.115050 |
| QUANTI-Blue™ | Synthesis and evaluation of a new class of MIF-inhibitors in activated macrop... | 2022 | Eur J Med Chem. | Garai J. et al. | DOI: 10.1016/j.ejmech.2022.115050 |
| Poly(I:C) HMW | CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment res... | 2022 | Cell Rep. | Tilsed C.M. et al. | DOI: 10.1016/j.celrep.2022.111874 |
| G418 (Geneticin) | Production cell analysis and compound-based boosting of small extracellular v... | 2022 | Biotechnol Bioeng. | Keysberg C. et al. | DOI: 10.1002/bit.28322 |
| PMA - Phorbol myristate acetate | JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activat... | 2022 | Sci Rep. | Lee G. et al. | DOI: 10.1038/s41598-022-27129-3 |
| ATP | JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activat... | 2022 | Sci Rep. | Lee G. et al. | DOI: 10.1038/s41598-022-27129-3 |
| Pam3CSK4 | Lipopolysaccharide from Porphyromonas gingivalis, but Not from Porphyromonas ... | 2022 | Int J Mol Sci. | Veloso P. et al. | DOI: 10.3390/ijms231710011 |
| Pan-Caspase inhibitor - Z-VAD-FMK | Transglutaminase type 2-dependent crosslinking of IRF3 in dying melanoma cells. | 2022 | Cell Death Discov. | Occhigrossi L. et al. | DOI: 10.1038/s41420-022-01278-w |